Barclays Downgrades Sarepta Therapeutics (SRPT) to Equalweight

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/1/2026

1. SPY
2. MDT
3. SPGI
4. USO
5. AAPL
6. ENOV
7. AON
8. AZN
9. BLSM
10. KRMN

Go back to Barclays Downgrades Sarepta Therapeutics (SRPT) to Equalweight
SAREPTA THERAP (NASDAQ: SRPT) Delayed: 21.66 +0.63 (3.00%)
Previous Close $21.03    52 Week High $63.73 
Open $20.88    52 Week Low $8.00 
Day High $21.82    P/E N/A 
Day Low $20.55    EPS $-5.69 
Volume 1,092,611